Cargando…

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada

BACKGROUND: The influenza A(H3N2) vaccine was updated from clade 3C.3a in 2015–2016 to 3C.2a for 2016–2017 and 2017–2018. Circulating 3C.2a viruses showed considerable hemagglutinin glycoprotein diversification and the egg-adapted vaccine also bore mutations. METHODS: Vaccine effectiveness (VE) in 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skowronski, Danuta M, Leir, Siobhan, Sabaiduc, Suzana, Chambers, Catharine, Zou, Macy, Rose, Caren, Olsha, Romy, Dickinson, James A, Winter, Anne-Luise, Jassem, Agatha, Gubbay, Jonathan B, Drews, Steven J, Charest, Hugues, Chan, Tracy, Hickman, Rebecca, Bastien, Nathalie, Li, Yan, Krajden, Mel, De Serres, Gaston
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016427/ https://www.ncbi.nlm.nih.gov/pubmed/32215564 http://dx.doi.org/10.1093/infdis/jiaa138

Ejemplares similares

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020
por: Skowronski, Danuta M, et al.
Publicado: (2020)

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic
por: Skowronski, Danuta M, et al.
Publicado: (2019)

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018
por: Skowronski, Danuta M, et al.
Publicado: (2018)

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
por: Skowronski, Danuta M, et al.
Publicado: (2023)

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
por: Kim, Shinhye, et al.
Publicado: (2022)

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?
por: Chambers, Catharine, et al.
Publicado: (2018)

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season
por: Skowronski, Danuta M., et al.
Publicado: (2016)

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010–2011 to 2015–2016, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2017)

Influenza Classification Suite: An automated Galaxy workflow for rapid influenza sequence analysis
por: Eisler, Diane, et al.
Publicado: (2020)

Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
por: Skowronski, Danuta M., et al.
Publicado: (2014)

Subclustering In Clusters
por: Godlowski, W
Publicado: (2000)

SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
por: El Adam, Shiraz, et al.
Publicado: (2022)

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
por: Skowronski, Danuta M, et al.
Publicado: (2011)

Acknowledgement to Reviewers of Vaccines in 2017
Publicado: (2018)

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada
por: Skowronski, Danuta M., et al.
Publicado: (2022)

Peptide-Based Immunotherapeutics and Vaccines 2017
por: Reche, Pedro, et al.
Publicado: (2018)

The 2017 Keystone Symposium on HIV Vaccines
por: Cottrell, Christopher A., et al.
Publicado: (2017)

Global Routine Vaccination Coverage — 2017
por: VanderEnde, Kristin, et al.
Publicado: (2018)

Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010–2011 Season
por: Kwong, Jeffrey C., et al.
Publicado: (2013)

Isolation and Annotation of the Genome Sequences of Bacteriophages InvictusManeo (Subcluster K5) and Netyap (Subcluster L2)
por: Flota, Maximiliano F., et al.
Publicado: (2022)

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2021)

2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network
por: Bettinger, Julie A, et al.
Publicado: (2020)

Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits
por: De Serres, Gaston, et al.
Publicado: (2018)

2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018)

Identification of novel genera and subcluster classifications for mycobacteriophages
por: O’Connell, Laura M., et al.
Publicado: (2023)

Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015
por: Payne, Michael, et al.
Publicado: (2018)

Vaccinations and Vaccinators’ Tracking System in Island Settlements: CHAD 2017-2018
por: Atagbaza, Ajiri, et al.
Publicado: (2021)

Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada
por: Skowronski, Danuta M, et al.
Publicado: (2022)

ASVAC2017: 6th Asian Vaccine Conference
por: Goh, Daniel Yam Thiam, et al.
Publicado: (2017)

Genome Sequences of Five B1 Subcluster Mycobacteriophages
por: Breakwell, Donald P., et al.
Publicado: (2013)

Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium
por: Coelho, Camila Henriques, et al.
Publicado: (2017)

Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015
por: Gilca, Rodica, et al.
Publicado: (2015)

Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement
por: De Serres, Gaston, et al.
Publicado: (2017)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
por: Grassly, Nicholas C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8t00bvp8ch8q623p06572mjp53